[Treatment of subacute cutaneous lupus erythematosus with thalidomide].
A patient with subacute-cutaneous lupus erythematosus showed no response to corticosteroids and azathioprine. Treatment with thalidomide resulted in a dramatic clearing of skin lesions but failed to improve pathological laboratory tests.
D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D007668:Kidney / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012867:Skin / Q000473:pathology; D013792:Thalidomide / Q000627:therapeutic use*
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D013792:Thalidomide; D001379:Azathioprine; D008775:Methylprednisolone
Behandlung eines subakut-kutanen Lupus erythematodes mit Thalidomid.